Jin-hee Park
Daegu, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Chronic oral administration of ibrutinib prevents long-term memory deficits and reduces AD pathology and neuroinflammatory responses in a mouse model of AD.
Journal: Molecular brain
Published: March 03, 2025
Felodipine attenuates neuroinflammatory responses and tau hyperphosphorylation through JNK/P38 signaling in tau-overexpressing AD mice.
Journal: Molecular brain
Published: July 11, 2024
Erlotinib regulates short-term memory, tau/Aβ pathology, and astrogliosis in mouse models of AD.
Journal: Frontiers in immunology
Published: April 22, 2024
L-DOPA regulates neuroinflammation and Aβ pathology through NEP and ADAM17 in a mouse model of AD.
Journal: Molecular brain
Published: February 18, 2024
Profiling tyrosine kinase inhibitors as AD therapeutics in a mouse model of AD.
Journal: Molecular brain
Published: June 18, 2023
A Study on the Factors Influencing Smoking in Multicultural Youths in Korea.
Journal: Healthcare (Basel, Switzerland)
Published: April 07, 2023
Lomerizine inhibits LPS-mediated neuroinflammation and tau hyperphosphorylation by modulating NLRP3, DYRK1A, and GSK3α/β.
Journal: Frontiers in immunology
Published: January 25, 2023
Reelin and APP Cooperatively Modulate Dendritic Spine Formation In Vitro and In Vivo.
Journal: Experimental neurobiology
Published: November 15, 2022
Factors Influencing Smoking among Multicultural Adolescents.
Journal: International journal of environmental research and public health
Published: August 16, 2022
Donepezil ameliorates Aβ pathology but not tau pathology in 5xFAD mice.
Journal: Molecular brain
Published: June 30, 2022
Inhibiting EGFR/HER-2 ameliorates neuroinflammatory responses and the early stage of tau pathology through DYRK1A.
Journal: Frontiers in immunology
Published: April 25, 2022
Nilotinib modulates LPS-induced cognitive impairment and neuroinflammatory responses by regulating P38/STAT3 signaling.
Journal: Journal of neuroinflammation
Published: March 04, 2022
Last Updated: 09/26/2026